Efficacy of Percutaneous Electrolysis in the Treatment of Achilles Tendinopathy
NCT: NCT05301959 · RECRUITING
Brief Summary
Achilles tendinopathy (AT) is one of the most reported myotendinous pathologies due to overuse in the literature. In the general adult population, its incidence is 2.35 cases per 1,000 patients, with no difference between men and women. The international literature reports that up to 29% of patients fail with conservative treatment. Within physiotherapy, new alternatives for the treatment of tendinopathies arise, applying electric currents percutaneously, which from a mechanical effect associated to the use of a needle and an electric effect by the use of galvanic currents, generate a local inflammatory response; activation of the central nervous system and analgesia. The aim of the research is to evaluate the efficacy of adding low intensity percutaneous electrolysis to the treatment with a high load eccentric exercise program based on the protocol of Silbernagel et al. in adults with Achilles tendinopathy to improve its functionality. A randomized, double-blind, blinded, evaluator-blinded, controlled clinical trial will be conducted in parallel groups (experimental treatment vs. sham treatment), with a follow-up at 26 and 52 weeks after the first intervention. Non-probability and intentional sampling will be performed.
Frequently Asked Questions
What is Efficacy of Percutaneous Electrolysis in the Treatment of Achilles Tendinopathy?
Efficacy of Percutaneous Electrolysis in the Treatment of Achilles Tendinopathy is a clinical trial registered under NCT05301959. Current status: RECRUITING.
What is the status of NCT05301959?
The current status of NCT05301959 (Efficacy of Percutaneous Electrolysis in the Treatment of Achilles Tendinopathy) is: RECRUITING.
When did Efficacy of Percutaneous Electrolysis in the Treatment of Achilles Tendinopathy start?
Efficacy of Percutaneous Electrolysis in the Treatment of Achilles Tendinopathy started on 2023-07-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.